atropine has been researched along with netilmicin in 7 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (netilmicin) | Trials (netilmicin) | Recent Studies (post-2010) (netilmicin) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 1,108 | 190 | 55 |
Protein | Taxonomy | atropine (IC50) | netilmicin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.02 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.02 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
7 other study(ies) available for atropine and netilmicin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |